Intervention

caffeine

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions5

Lead sponsors shown5

Clinical trials

5 shown

The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 DiabetesNCT02929901 · 2016-12-01

Arrhythmic Effects of Hight Dose CaffeineNCT02045992 · 2013-04-01

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid TumorsNCT01596647 · 2012-05-01

Effects of Caffeine on Methacholine Challenge and Exhaled Nitric Oxide Levels.NCT01057875 · 2010-01-01

The Acute Effects of Coffee on Glucose MetabolismNCT00950898 · 2006-11-01

Common conditions

Advanced Solid Tumors, Excluding Breast Cancer1 Arrhythmia1 Asthma1 Type 2 Diabetes1 Type 2 Diabetes Nonalcoholic Fatty Liver1

Leading sponsors

Brooklyn College of the City University of New York1 Luis Eduardo Paim Rohde1 National Nutrition and Food Technology Institute1 Novartis Pharmaceuticals1 University of Saskatchewan1

Trial status mix

COMPLETED4

UNKNOWN1

Phase mix

NA3

PHASE11

PHASE21

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.